Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 3/20 | 0.71 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.51 |
| ▸ | ALPI | P09923 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | XIAP | P98170 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | EGFR | P00533 | 1/20 | 0.49 |
| ▸ | LCK | P06239 | 1/20 | 0.49 |
| ▸ | FYN | P06241 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HTR2A | P28223 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | TPH1 | P17752 | 1/20 | 0.46 |
| ▸ | GRB2 | P62993 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL28430992 | 1.00 | SLC7A5 (0.71) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL180585 | 1.00 | SLC7A5 (0.71) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL27531942 | 0.93 | SLC7A5 (0.61) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL7764501 | 0.93 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL7764495 | 0.93 | SLC7A5 (0.65) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1724134 | 0.92 | SLC7A5 (0.60) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL27625516 | 0.92 | SLC7A5 (0.60) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL28477318 | 0.91 | SLC7A5 (0.58) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL8630269 | 0.91 | SLC7A5 (0.58) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1585313 | 0.91 | SLC7A5 (0.58) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117447706-A | Preparation method and application of methionine-tyrosine difunctional porous material | 南京工业大学 | 2024-01-26 | — | — | CN | claimed |
| US-20200353088-A1 | PEPTIDE CONJUGATE CGRP RECEPTOR ANTAGONISTS AND METHODS OF PREPARATION AND USES THEREOF | AUCKLAND UNISERVICES LIMITED (NZ) | 2020-11-12 | — | — | US | claimed |
| EP-3707157-A1 | PEPTIDE CONJUGATE CGRP RECEPTOR ANTAGONISTS AND METHODS OF PREPARATION AND USES THEREOF | Auckland Uniservices Limited (NZ) | 2020-09-16 | — | — | EP | claimed |
| CN-111479823-A | Peptide conjugate CGRP receptor antagonist and preparation method and application thereof | 奥克兰联合服务有限公司 | 2020-07-31 | — | — | CN | claimed |
| US-7927864-B2 | Methods, kits, and compositions for detecting enzyme activity | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2011-04-19 | — | — | US | claimed |
| US-20090148851-A1 | Methods, kits, and compositions for detecting enzyme activity | OWEN JOHN | 2009-06-11 | — | — | US | claimed |
| US-7468258-B2 | Self-quenching homofluorophore compositions for detecting enzyme activity | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2008-12-23 | — | — | US | claimed |
| US-20070212696-A1 | Self-quenching homofluorophore compositions for detecting enzyme activity | WAKE FOREST UNIVERSITY HEALTH SCIENCES | 2007-09-13 | — | — | US | claimed |
| CN-117615774-A | PD-L1 binding peptides and peptide complexes and methods of use thereof | 弗莱德哈钦森癌症中心 | 2024-02-27 | — | — | CN | disclosed |
| CN-117482911-A | Preparation method and application of valine porous silicon modified graphene composite material | 南京工业大学 | 2024-02-02 | — | — | CN | disclosed |
| CN-117447706-A | Preparation method and application of methionine-tyrosine difunctional porous material | 南京工业大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-117447706-A | Preparation method and application of methionine-tyrosine difunctional porous material | 南京工业大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-117447706-A | Preparation method and application of methionine-tyrosine difunctional porous material | 南京工业大学 | 2024-01-26 | — | — | CN | disclosed |
| EP-4251190-A1 | PD-L1 BINDING PEPTIDES AND PEPTIDE COMPLEXES AND METHODS OF USE THEREOF | Fred Hutchinson Cancer Center (US) | 2023-10-04 | — | — | EP | disclosed |
| EP-1144693-A3 | DETECTION OF ANTI-HEPATITIS B DRUG RESISTANCE | INNOGENETICS N.V. (BE) | 2001-11-28 | — | — | EP | disclosed |
| EP-1144693-A2 | DETECTION OF ANTI-HEPATITIS B DRUG RESISTANCE | INNOGENETICS N.V. (BE) | 2001-10-17 | — | — | EP | disclosed |
| WO-2001004358-A2 | DETECTION OF ANTI-HEPATITIS B DRUG RESISTANCE | INNOGENETICS N.V. (BE) | 2001-01-18 | — | — | WO | disclosed |
| US-5239061-A | MODIFIED HUMAN HEMOGLOBIN, BLOOD SUBSTITUTES CONTAINING THE SAME, AND VECTORS FOR EXPRESSING THE MODIFIED HEMOGLOBIN | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1993-08-24 | — | — | US | disclosed |
| WO-1991019505-A1 | MODIFIED HUMAN HEMOGLOBIN, BLOOD SUBSTITUTES CONTAINING THE SAME, AND VECTORS FOR EXPRESSING THE MODIFIED HEMOGLOBIN | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1991-12-26 | — | — | WO | disclosed |
| US-5062935-A | METHOD OF VAPORIZING A SAMPLE SUBSTANCE | BRUKER-FRANZEN ANALYTIK GMBH (DE) | 1991-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200353088-A1 | PEPTIDE CONJUGATE CGRP RECEPTOR ANTAGONISTS AND METHODS OF PREPARATION AND USES THEREOF | CALCRL, CALCR, GRPR | SLC7A5 1069/4885PTGS1 1469/4885ALPI 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.